# Ashwagandha Stress Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/ashwagandha-stress-meta-analysis-evidence-review
Category: evidence-review
Summary: Ashwagandha Stress Meta-analysis has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed 
Last reviewed: 2026-05-26
Reviewed by: Migaku Evidence Review
# Ashwagandha Stress Meta-analysis: What the Evidence Says

## Quick Answer

Ashwagandha Stress Meta-analysis has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The Clinical Implications of Ashwagandha ( Withania somnifera L.) with a Special Reference to Side Effects—A Review | narrative review | 3 | 2026-03-09 | 10.3390/nu18050871 |

## What The Sources Report

- It is important to note that all cellular and biochemical markers of the immune system, which were improved, were still within the normal physiological range of the respective markers, indicating that the treatment did not give rise to uncontrolled immune stimulation. [Winther Kaj (2026); evidence level 3]
- In another in vivo rat model, where gout was induced by monosodium urate crystals, edema was reduced to normal levels, indicating a potent anti-inflammatory effect with ashwagandha treatment. [Winther Kaj (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For ashwagandha stress meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Winther Kaj (2026). The Clinical Implications of Ashwagandha ( Withania somnifera L.) with a Special Reference to Side Effects—A Review. DOI: 10.3390/nu18050871. PMCID: PMC12986965. PMID: 41830041. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12986965/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.